SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales declined to Rs. 56391.40 millions for the March 2024 quarter as compared to Rs. 59482.20 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2024 of Rs. 8676.00 millions grew from Rs.-10208.20 millionsThe Operating Profit of the company witnessed a decrease to 20124.10 millions from 24809.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 56391.40 59482.20 -5.20 202751.70 208121.40 -2.58 202751.70 208121.40 -2.58
Other Income 1188.80 1203.00 -1.18 5534.80 3292.90 68.08 5534.80 3292.90 68.08
PBIDT 20124.10 24809.50 -18.89 60533.70 67518.90 -10.35 60533.70 67518.90 -10.35
Interest 2175.90 1614.50 34.77 7840.80 4721.80 66.06 7840.80 4721.80 66.06
PBDT 17948.20 -6182.90 -390.29 50502.70 33419.20 51.12 50502.70 33419.20 51.12
Depreciation 3930.40 4119.80 -4.60 16006.20 16008.70 -0.02 16006.20 16008.70 -0.02
PBT 14017.80 -10302.70 -236.06 34496.50 17410.50 98.14 34496.50 17410.50 98.14
TAX 5341.80 -94.50 -5752.70 5914.70 503.30 1075.18 5914.70 503.30 1075.18
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 8676.00 -10208.20 -184.99 28581.80 16907.20 69.05 28581.80 16907.20 69.05
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 35.69 41.71 -14.44 29.86 32.44 -7.97 29.86 32.44 -7.97

Sun Pharma Inds. Share Price

1874.00 26.70 (1.45%)
11-May-2026 13:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.00
Dr. Reddys Lab 1294.85
Cipla 1322.00
Zydus Lifesciences 948.00
Lupin 2277.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×